The Committee on Medical, Military, Public and Municipal Affairs proposes the following amendment (LC-449.WAB0001H):

Amend the bill, as and if amended, by adding an appropriately numbered SECTION to read:

SECTION X. Section 40-43-30(50) of the S.C. Code is amended to read:

 (50) "Practice of pharmacy" means the:
  (a) interpretation, evaluation, and dispensing of prescription drug orders in the patient's best interest;
  (b) participation in drug and device selection, drug administration, prospective drug reviews, and drug or drug-related research;
  (c) provision of patient counseling and the provision of those acts or services necessary to provide pharmacy care and drug therapy management;
  (d) responsibility for compounding and labeling of drugs and devices, (except labeling by a manufacturer, repackager, or distributor or nonprescription drugs and commercially packaged legend drugs and devices) proper and safe storage of drugs and devices and maintenance of proper records for them;
  (e) initiation, ordering, and administration of flu and COVID tests waived under the federal clinical laboratory improvement amendments (CLIA) of 1988 and authorized by the Food and Drug Administration for influenza, SARS-COV-2, streptococcal pharyngitis, and others as approved by the Board of Medical Examiners and Board of Pharmacy. Pharmacists may delegate the task of administering tests provided for in this subsection to a trained pharmacy technician or pharmacy intern, but the pharmacist must perform any interpretation of the results;
  (f) initiate treatment of conditions identified in subitem (e) pursuant to identical joint written protocol issued by the Board of Medical Examiners and Board of Pharmacy which must be issued within ninety days of the effective date of this subitem and updated as needed but no less than annually;
  (f)(g) reporting of a person's flu or COVID test resultsreporting of tests performed pursuant to subitem (e) and treatment provided pursuant to subitem (f) and the referral of that patient for follow-up care to the health care provider identified by the patient or if none is identified, to an appropriate health care provider as needed; or
  (g)(h) the offering or performing of those acts, services, operations, or transactions necessary in the conduct, operation, education, management, and control of pharmacy.

Renumber sections to conform.

Amend title to conform.